{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T23:02:17Z","timestamp":1771282937078,"version":"3.50.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04563-1","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:12:08Z","timestamp":1771236728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["De-escalation strategies in the management of differentiated thyroid cancer"],"prefix":"10.1007","volume":"91","author":[{"given":"Mubeen Hussein","family":"Arawker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fitrat","family":"Habibullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantanu","family":"Baral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinguang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"4563_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2967\/jnumed.121.262402","volume":"63","author":"AM Avram","year":"2022","unstructured":"A.M. Avram, K. Zukotynski, H.R. Nadel, L. Giovanella, Management of differentiated thyroid cancer: the standard of care. J. Nucl. Med. 63, 189\u2013195 (2022)","journal-title":"J. Nucl. Med."},{"key":"4563_CR2","doi-asserted-by":"publisher","first-page":"R597","DOI":"10.1530\/ERC-19-0294","volume":"26","author":"L Lamartina","year":"2019","unstructured":"L. Lamartina, S. Leboulleux, M. Terroir, D. Hartl, M. Schlumberger, An update on the management of low-risk differentiated thyroid cancer. Endocr. Relat. Cancer. 26, R597\u2013R610 (2019)","journal-title":"Endocr. Relat. Cancer"},{"key":"4563_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"C.M. Kitahara, A.B. Schneider, Epidemiology of thyroid cancer. Cancer Epidemiol. Biomarkers Prev. 31, 1284\u20131297 (2022)","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"4563_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMp1604412","volume":"375","author":"S Vaccarella","year":"2016","unstructured":"S. Vaccarella, S. Franceschi, F. Bray, C.P. Wild, M. Plummer et al., Worldwide Thyroid-Cancer epidemic? The increasing impact of overdiagnosis. N Engl. J. Med. 375, 614\u2013617 (2016)","journal-title":"N Engl. J. Med."},{"key":"4563_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000468927","volume":"6","author":"NS Andresen","year":"2017","unstructured":"N.S. Andresen, J.M. Buatti, H.H. Tewfik, N.A. Pagedar, C.M. Anderson et al., Radioiodine ablation following thyroidectomy for differentiated thyroid cancer: literature review of Utility, Dose, and toxicity. Eur. Thyroid J. 6, 187\u2013196 (2017)","journal-title":"Eur. Thyroid J."},{"key":"4563_CR6","doi-asserted-by":"crossref","unstructured":"Arrangoiz R, Cordera F, Caba D, Moreno E, Luque-de-Leon E, et al. Thyroid Cancer. International Journal of Otolaryngology and Head & Neck Surger y 8: 217\u2013270","DOI":"10.4236\/ijohns.2019.86024"},{"key":"4563_CR7","doi-asserted-by":"publisher","first-page":"e228722","DOI":"10.1001\/jamanetworkopen.2022.8722","volume":"5","author":"PH Dedhia","year":"2022","unstructured":"P.H. Dedhia, M.C. Saucke, K.L. Long, G.M. Doherty, S.C. Pitt, Physician perspectives of overdiagnosis and overtreatment of Low-Risk papillary thyroid cancer in the US. JAMA Netw. Open. 5, e228722 (2022)","journal-title":"JAMA Netw. Open."},{"key":"4563_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.6004\/jnccn.2010.0094","volume":"8","author":"SL Lee","year":"2010","unstructured":"S.L. Lee, Complications of radioactive iodine treatment of thyroid carcinoma. J. Natl. Compr. Canc Netw. 8, 1277\u20131286 (2010). quiz 1287","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"4563_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1089\/thy.2020.0356","volume":"31","author":"MW Piek","year":"2021","unstructured":"M.W. Piek, E.L. Postma, van R. Leeuwaarde, de J.P. Boer, A.M.E. Bos et al., The effect of radioactive iodine therapy on ovarian function and fertility in female thyroid cancer patients: A systematic review and Meta-Analysis. Thyroid. 31, 658\u2013668 (2021)","journal-title":"Thyroid"},{"key":"4563_CR10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaoto.2022.0660","volume":"148","author":"N Uppal","year":"2022","unstructured":"N. Uppal, C. Cunningham Nee Lubitz, B. James, The cost and financial burden of thyroid cancer on patients in the US: A review and directions for future research. JAMA Otolaryngol. Head Neck Surg. 148, 568\u2013575 (2022)","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"4563_CR11","doi-asserted-by":"crossref","unstructured":"M.M.A.A.L.A. Morgan, Y. Weerakkody, (2016) ATA guidelines for assessment of thyroid nodules. Reference article, Radiopaedia.org (Accessed on 16 Jun 2025)","DOI":"10.53347\/rID-44355"},{"key":"4563_CR12","unstructured":"avD AHL TI-RADS - Thyroid Imaging Reporting and Data System Accessed on 16th, June 2025 from https:\/\/radiologyassistant.nl\/head-neck\/ti-rads\/ti-rads2025)"},{"key":"4563_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejso.2017.03.005","volume":"44","author":"KJ Kovatch","year":"2018","unstructured":"K.J. Kovatch, C.W. Hoban, A.G. Shuman, Thyroid cancer surgery guidelines in an era of de-escalation. Eur. J. Surg. Oncol. 44, 297\u2013306 (2018)","journal-title":"Eur. J. Surg. Oncol."},{"key":"4563_CR14","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1245\/s10434-025-17063-9","volume":"32","author":"T.M. Ullmann","year":"2025","unstructured":"T.M. Ullmann, J.A. Sosa, The landmark series: extent of surgery for Low-Risk differentiated thyroid cancer. Ann. Surg. Oncol. 32, 3119\u20133125 (2025)","journal-title":"Ann. Surg. Oncol."},{"key":"4563_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"R.I. Haddad, L. Bischoff, D. Ball, V. Bernet, E. Blomain et al., Thyroid Carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc Netw. 20, 925\u2013951 (2022)","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"4563_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1089\/thy.2023.0313","volume":"34","author":"AC Cavallo","year":"2024","unstructured":"A.C. Cavallo, F. Pitoia, J. Roberti, P. Brenzoni, M. Lencioni et al., Optimizing diagnostic accuracy of fine needle aspiration biopsy calcitonin measurements in detecting medullary thyroid carcinoma. Thyroid. 34, 186\u2013196 (2024)","journal-title":"Thyroid"},{"key":"4563_CR17","doi-asserted-by":"publisher","first-page":"1278816","DOI":"10.3389\/fonc.2024.1278816","volume":"14","author":"P Trimboli","year":"2024","unstructured":"P. Trimboli, G. Peloni, D. Confalonieri, E. Gamarra, T. Piticchio et al., Determinants of Circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma. Front. Oncol. 14, 1278816 (2024)","journal-title":"Front. Oncol."},{"key":"4563_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"M.D. Ringel, J.A. Sosa, Z. Baloch, L. Bischoff, G. Bloom et al., 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer. Thyroid. 35, 841\u2013985 (2025)","journal-title":"Thyroid"},{"key":"4563_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel et al., 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 26, 1\u2013133 (2016)","journal-title":"Thyroid"},{"key":"4563_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s12020-021-02788-w","volume":"74","author":"S Bakkar","year":"2021","unstructured":"S. Bakkar, K. Al-Omar, G. Donatini, Q. Aljarrah, T.S. Papavramidis et al., Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer. Endocrine. 74, 611\u2013615 (2021)","journal-title":"Endocrine"},{"key":"4563_CR21","first-page":"34","volume":"22","author":"K RSVSK","year":"2023","unstructured":"K RSVSK, Evaluation of thyroid nodules by high resolution ultrasonography with histopathological correlation. IOSR J. Dent. Med. Sci. (IOSR-JDMS). 22, 34\u201337 (2023)","journal-title":"IOSR J. Dent. Med. Sci. (IOSR-JDMS)"},{"key":"4563_CR22","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3892\/ol.2017.6385","volume":"14","author":"S Li","year":"2017","unstructured":"S. Li, L. Liu, G. Lv, Diagnostic value of strain elastography for differentiating benign and malignant soft tissue masses. Oncol. Lett. 14, 2041\u20132044 (2017)","journal-title":"Oncol. Lett."},{"key":"4563_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.7863\/jum.2008.27.10.1425","volume":"27","author":"BM Kim","year":"2008","unstructured":"B.M. Kim, M.J. Kim, E.K. Kim, J.Y. Kwak, S.W. Hong et al., Sonographic differentiation of thyroid nodules with eggshell calcifications. J. Ultrasound Med. 27, 1425\u20131430 (2008)","journal-title":"J. Ultrasound Med."},{"issue":"17","key":"4563_CR24","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.3390\/cancers13174316","volume":"13","author":"G. Russ","year":"2021","unstructured":"G. Russ, P. Trimboli, C. Buffet, The new era of TIRADSs to stratify the risk of malignancy of thyroid nodules: Strengths, weaknesses and pitfalls. Cancers (Basel). 13(17), 4316 (2021)","journal-title":"Cancers (Basel)"},{"key":"4563_CR25","doi-asserted-by":"publisher","first-page":"e250113","DOI":"10.1530\/ETJ-25-0113","volume":"14","author":"P Trimboli","year":"2025","unstructured":"P. Trimboli, P. Makovac, A. Colombo, L. Ruinelli, C. Dobrinja et al., Analysis of FNAC indication in thyroid nodules assessed as low risk according to various tiradss. Eur. Thyroid J. 14, e250113 (2025)","journal-title":"Eur. Thyroid J."},{"issue":"24","key":"4563_CR26","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.3390\/cancers16244249","volume":"16","author":"A.E. da Payne","year":"2024","unstructured":"A.E. Payne, C. Lefebvre, M. Minello, M. Rajab, da S.D. Silva et al., Molecular mutations and clinical behavior in Bethesda III and IV thyroid nodules: A comparative study. Cancers (Basel). 16(24), 4249 (2024)","journal-title":"Cancers (Basel)"},{"key":"4563_CR27","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jama.2013.3190","volume":"309","author":"M Xing","year":"2013","unstructured":"M. Xing, A.S. Alzahrani, K.A. Carson, D. Viola, R. Elisei et al., Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309, 1493\u20131501 (2013)","journal-title":"JAMA"},{"key":"4563_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12957-016-0979-1","volume":"14","author":"C Liu","year":"2016","unstructured":"C. Liu, T. Chen, Z. Liu, Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World J. Surg. Oncol. 14, 241 (2016)","journal-title":"World J. Surg. Oncol."},{"key":"4563_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-13-0210","volume":"20","author":"X Liu","year":"2013","unstructured":"X. Liu, J. Bishop, Y. Shan, S. Pai, D. Liu et al., Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr. Relat. Cancer. 20, 603\u2013610 (2013)","journal-title":"Endocr. Relat. Cancer"},{"key":"4563_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/thy.2016.0350","volume":"27","author":"S Moon","year":"2017","unstructured":"S. Moon, Y.S. Song, Y.A. Kim, J.A. Lim, S.W. Cho et al., Effects of coexistent BRAF(V600E) and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer: A Meta-Analysis. Thyroid. 27, 651\u2013660 (2017)","journal-title":"Thyroid"},{"key":"4563_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4158\/EP-2018-0395","volume":"25","author":"RM Harrell","year":"2019","unstructured":"R.M. Harrell, S.A. Eyerly-Webb, A.C. Golding, C.M. Edwards, D.N. Bimston, Statistical comparison of Afirma Gsc and Afirma gec outcomes in a community endocrine surgical practice: early findings. Endocr. Pract. 25, 161\u2013164 (2019)","journal-title":"Endocr. Pract."},{"key":"4563_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","volume":"5","author":"DL Steward","year":"2019","unstructured":"D.L. Steward, S.E. Carty, R.S. Sippel, S.P. Yang, J.A. Sosa et al., Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: A prospective blinded multicenter study. JAMA Oncol. 5, 204\u2013212 (2019)","journal-title":"JAMA Oncol."},{"key":"4563_CR33","doi-asserted-by":"publisher","first-page":"191602162412918","DOI":"10.1177\/19160216241291806","volume":"53","author":"C MacKay","year":"2024","unstructured":"C. MacKay, B. Turner, S. Clarke, T. Wallace, M.H. Rigby, Cost-Effectiveness analysis of molecular testing for indeterminate thyroid nodules in Nova Scotia. J. Otolaryngol. Head Neck Surg. 53, 19160216241291806 (2024)","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"4563_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/dc.25500","volume":"53","author":"Z Zhu","year":"2025","unstructured":"Z. Zhu, H. Tong, X. Qian, M. Xue, A. Sun et al., Panel testing of BRAF mutation, RAS mutation, and RET\/PTC rearrangements or RET mutation using Fine-Needle aspiration specimens in evaluation of thyroid carcinoma. Diagn. Cytopathol. 53, 485\u2013493 (2025)","journal-title":"Diagn. Cytopathol."},{"key":"4563_CR35","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1158\/1078-0432.CCR-25-0270","volume":"31","author":"M Ding","year":"2025","unstructured":"M. Ding, G. Wu, S. Zhang, R. Xie, J. Yuan et al., Clinical implications and application of molecular testing in the diagnosis and management of thyroid nodules in the Chinese population. Clin. Cancer Res. 31, 4996\u20135005 (2025)","journal-title":"Clin. Cancer Res."},{"key":"4563_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.32074\/1591-951X-887","volume":"115","author":"C Fumagalli","year":"2023","unstructured":"C. Fumagalli, G. Serio, Molecular testing in indeterminate thyroid nodules: an additional tool for clinical decision-making. Pathologica. 115, 205\u2013216 (2023)","journal-title":"Pathologica"},{"issue":"3","key":"4563_CR37","doi-asserted-by":"publisher","first-page":"Article e210124","DOI":"10.1530\/ETJ-21-0124","volume":"11","author":"M. Ren","year":"2022","unstructured":"M. Ren, Q. Yao, L. Bao, Z. Wang, R. Wei et al., Diagnostic performance of next-generation sequencing and genetic profiling in thyroid nodules from a single center in China. Eur. Thyroid J. 11(3), Article e210124 (2022)","journal-title":"Eur. Thyroid J."},{"key":"4563_CR38","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.3390\/ijms26094225","volume":"26","author":"M Capezzone","year":"2025","unstructured":"M. Capezzone, M. Rossi, S. Bardi, E.M. Morabito, G. Dalmazio et al., Diagnostic performance of Next-Generation sequencing (NGS) in indeterminate thyroid nodules: A single hospital experience. Int. J. Mol. Sci. 26, 4225 (2025)","journal-title":"Int. J. Mol. Sci."},{"key":"4563_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3803\/EnM.2024.1937","volume":"39","author":"MJ Kim","year":"2024","unstructured":"M.J. Kim, J.H. Moon, E.K. Lee, Y.S. Song, K.Y. Jung et al., Active surveillance for Low-Risk thyroid cancers: A review of current practice guidelines. Endocrinol. Metab. (Seoul). 39, 47\u201360 (2024)","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"4563_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13044-023-00148-6","volume":"16","author":"A Smulever","year":"2023","unstructured":"A. Smulever, F. Pitoia, Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience. Thyroid Res. 16, 6 (2023)","journal-title":"Thyroid Res."},{"key":"4563_CR41","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.21037\/gs-2019-catp-03","volume":"9","author":"Y Ito","year":"2020","unstructured":"Y. Ito, A. Miyauchi, Active surveillance of low-risk papillary thyroid microcarcinomas. Gland Surg. 9, 1663\u20131673 (2020)","journal-title":"Gland Surg."},{"key":"4563_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","volume":"34","author":"Y Ito","year":"2010","unstructured":"Y. Ito, A. Miyauchi, H. Inoue, M. Fukushima, M. Kihara et al., An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J. Surg. 34, 28\u201335 (2010)","journal-title":"World J. Surg."},{"key":"4563_CR43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1089\/thy.2023.0076","volume":"33","author":"A Miyauchi","year":"2023","unstructured":"A. Miyauchi, Y. Ito, M. Fujishima, A. Miya, N. Onoda et al., Long-Term outcomes of active surveillance and immediate surgery for adult patients with Low-Risk papillary thyroid microcarcinoma: 30-Year experience. Thyroid. 33, 817\u2013825 (2023)","journal-title":"Thyroid"},{"key":"4563_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3803\/EnM.2022.1553","volume":"37","author":"C.K. Jung","year":"2022","unstructured":"C.K. Jung, A. Bychkov, K. Kakudo, Update from the 2022 world health organization classification of Thyro id tumors: A standardized diagnostic approach. Endocrinol. Metabolism. 37, 703\u2013718 (2022)","journal-title":"Endocrinol. Metabolism"},{"key":"4563_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Z.W. Baloch, S.L. Asa, J.A. Barletta, R.A. Ghossein, C.C. Juhlin et al., Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33, 27\u201363 (2022)","journal-title":"Endocr. Pathol."},{"key":"4563_CR46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1507\/endocrj.EJ20-0025","volume":"67","author":"Y Ito","year":"2020","unstructured":"Y. Ito, N. Onoda, T. Okamoto, The revised clinical practice guidelines on the management of thyroid tumors by the Japan associations of endocrine surgeons: core questions and recommendations for treatments of thyroid cancer. Endocr. J. 67, 669\u2013717 (2020)","journal-title":"Endocr. J."},{"key":"4563_CR47","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1089\/thy.2021.0614","volume":"32","author":"EK Lee","year":"2022","unstructured":"E.K. Lee, J.H. Moon, Y. Hwangbo, C.H. Ryu, S.W. Cho et al., Progression of Low-Risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea. Thyroid. 32, 1328\u20131336 (2022)","journal-title":"Thyroid"},{"key":"4563_CR48","first-page":"1","volume-title":"Handbook of the Behavior and Psychology of Disease","author":"I Vainer","year":"2025","unstructured":"I. Vainer, D. Yaniv, Impact of thyroid cancer on behavior and psychology, in Handbook of the Behavior and Psychology of Disease, ed. by C.R. Martin, V.R. Preedy, V.B. Patel, R. Rajendram (Springer Nature Switzerland, Cham, 2025), pp. 1\u201321"},{"key":"4563_CR49","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1210\/clinem\/dgad748","volume":"109","author":"BH Kim","year":"2024","unstructured":"B.H. Kim, S.R. Ryu, J.W. Lee, C.M. Song, Y.B. Ji et al., Longitudinal changes in quality of life before and after thyroidectomy in patients with differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 109, 1505\u20131516 (2024)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"4563_CR50","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.3390\/jcm13185472","volume":"13","author":"T.-C. Changchien","year":"2024","unstructured":"T.-C. Changchien, Y.-C. Yen, Y.-C. Lu, Mental health and quality of life of patients with differentiated thyroid cancer pre and post radioactive iodine treatment: A prospective study. J. Clin. Med. 13(18), 5472 (2024)","journal-title":"J. Clin. Med."},{"key":"4563_CR51","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.surg.2011.08.016","volume":"151","author":"IJ Nixon","year":"2012","unstructured":"I.J. Nixon, I. Ganly, S.G. Patel, F.L. Palmer, M.M. Whitcher et al., Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery. 151, 571\u2013579 (2012)","journal-title":"Surgery"},{"key":"4563_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/biomedicines13020433","volume":"13","author":"I Gerardi","year":"2025","unstructured":"I. Gerardi, B. Verro, R. Amodei, P. Richiusa, C. Saraniti, Thyroidectomy and its complications: A comprehensive analysis. Biomedicines. 13, 433 (2025)","journal-title":"Biomedicines"},{"key":"4563_CR53","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.surg.2013.06.039","volume":"154","author":"SK Snyder","year":"2013","unstructured":"S.K. Snyder, B.R. Sigmond, T.C. Lairmore, C.M. Govednik-Horny, A.K. Janicek et al., The long-term impact of routine intraoperative nerve monitoring during thyroid and parathyroid surgery. Surgery. 154, 704\u2013713 (2013)","journal-title":"Surgery"},{"key":"4563_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5001\/omj.2011.09","volume":"26","author":"Zakaria Recurrent Laryngeal","year":"2011","unstructured":"Zakaria Recurrent Laryngeal, Nerve injury in thyroid surgery. Oman Med. J. 26, 34\u201338 (2011)","journal-title":"Oman Med. J."},{"key":"4563_CR55","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5505\/ejm.2019.33254","volume":"24","author":"S Yuksekdag","year":"2019","unstructured":"S. Yuksekdag, A. Topcu, I. Deveci, E. Unal, Recurrent laryngeal nerve injury (RLNI) in total thyroidectomy with intraoperative nerve monitoring (IONM) and harmonic sealing instrument: A retrospective analysis and treatment results. Eastern J. Med. 24, 210\u2013214 (2019)","journal-title":"Eastern J. Med."},{"key":"4563_CR56","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"M.L. Brandi, J.P. Bilezikian, D. Shoback, R. Bouillon, B.L. Clarke et al., Management of hypoparathyroidism: summary statement and guidelines. J. Clin. Endocrinol. Metabolism. 101, 2273\u20132283 (2016)","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4563_CR57","doi-asserted-by":"crossref","unstructured":"A. Weiss, R.P. Parina, J.A. Tang, K.T. Brumund, D.C. Chang et al., (2015) Outcomes of thyroidectomy from a large California state database. Am J Surg 210: 1170\u20131176; discussion 1176\u20131177","DOI":"10.1016\/j.amjsurg.2015.08.011"},{"key":"4563_CR58","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.amjsurg.2020.06.052","volume":"220","author":"M Wilson","year":"2020","unstructured":"M. Wilson, A. Patel, W. Goldner, J. Baker, Z. Sayed et al., Postoperative thyroid hormone supplementation rates following thyroid lobectomy. Am. J. Surg. 220, 1169\u20131173 (2020)","journal-title":"Am. J. Surg."},{"key":"4563_CR59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00268-013-2260-x","volume":"38","author":"M Barczy\u0144ski","year":"2014","unstructured":"M. Barczy\u0144ski, A. Konturek, K. Pragacz, A. Papier, M. Stopa et al., Intraoperative nerve monitoring can reduce prevalence of recurrent laryngeal nerve injury in thyroid reoperations: results of a retrospective cohort study. World J. Surg. 38, 599\u2013606 (2014)","journal-title":"World J. Surg."},{"key":"4563_CR60","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1245\/s10434-013-2897-6","volume":"20","author":"DE Gyorki","year":"2013","unstructured":"D.E. Gyorki, B. Untch, R.M. Tuttle, A.R. Shaha, Prophylactic central neck dissection in differentiated thyroid cancer: an assessment of the evidence. Ann. Surg. Oncol. 20, 2285\u20132289 (2013)","journal-title":"Ann. Surg. Oncol."},{"key":"4563_CR61","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1245\/s10434-010-1137-6","volume":"17","author":"T Zetoune","year":"2010","unstructured":"T. Zetoune, X. Keutgen, D. Buitrago, H. Aldailami, H. Shao et al., Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: A Meta-analysis. Ann. Surg. Oncol. 17, 3287\u20133293 (2010)","journal-title":"Ann. Surg. Oncol."},{"key":"4563_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12020-025-04209-8","volume":"89","author":"S Bakkar","year":"2025","unstructured":"S. Bakkar, A. Chorti, T. Papavramidis, M. AlHalaseh, Q. Aljarrah et al., Verifying the oncologic rationale of prophylactic central compartment neck dissection in the management of papillary thyroid carcinoma using a pathologic spectrum of nodal metastases characteristics. A prospective comparative study. Endocrine. 89, 119\u2013124 (2025)","journal-title":"Endocrine"},{"key":"4563_CR63","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/jamaoto.2019.1752","volume":"145","author":"C Meltzer","year":"2019","unstructured":"C. Meltzer, M. Hull, A. Sundang, J.L. Adams, Association between annual surgeon total thyroidectomy volume and transient and permanent complications. JAMA Otolaryngology\u2013Head Neck Surg. 145, 830\u2013837 (2019)","journal-title":"JAMA Otolaryngology\u2013Head Neck Surg."},{"key":"4563_CR64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00423-020-01907-x","volume":"405","author":"K Lorenz","year":"2020","unstructured":"K. Lorenz, M. Raffaeli, M. Barczy\u0144ski, L. Lorente-Poch, J. Sancho, Volume, outcomes, and quality standards in thyroid surgery: an evidence-based analysis\u2014European society of endocrine surgeons (ESES) positional statement. Langenbeck\u2019s Archives Surg. 405, 401\u2013425 (2020)","journal-title":"Langenbeck\u2019s Archives Surg."},{"key":"4563_CR65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-031-37135-6_12","volume-title":"Controversies in Thyroid Nodules and Differentiated Thyroid Cancer: A Case-Based Approach","author":"F Romero-Hernandez","year":"2023","unstructured":"F. Romero-Hernandez, M.A. Adam, Impact of surgeon volume in thyroid operations, in Controversies in Thyroid Nodules and Differentiated Thyroid Cancer: A Case-Based Approach, ed. by S.A. Roman, W.T. Shen, J.A. Sosa (Springer International Publishing, Cham, 2023), pp. 131\u2013141"},{"key":"4563_CR66","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.21037\/atm-20-4554","volume":"8","author":"X Liu","year":"2020","unstructured":"X. Liu, X. Bian, C. Li, J. Xin, Q. Fu et al., Comparison of iPTH and calcium levels between total thyroidectomy and lobectomy: a prospective study of 840 thyroid cancers with three years of follow-up. Ann. Transl Med. 8, 1243 (2020)","journal-title":"Ann. Transl Med."},{"key":"4563_CR67","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s00268-022-06730-7","volume":"46","author":"S.L. Hillary","year":"2022","unstructured":"S.L. Hillary, J.E. Chooi, J. Wadsley, J.D. Newell-Price, N.J. Brown et al., Quality of life in Post-Surgical hypoparathyroidism (PoSH) in thyroid and parathyroid surgery. World J. Surg. 46, 3025\u20133033 (2022)","journal-title":"World J. Surg."},{"key":"4563_CR68","first-page":"618","volume":"68","author":"D.T. Joaquim","year":"2025","unstructured":"D.T. Joaquim, H.F. Kohler, J.G. Vartanian, L.P. Kowalski, Carvalho GBd predictive factors for permanent hypoparathyroidism following total Th yroidectomy: A retrospective cohort study of 5,671 cases. Archives Endocrinol. Metabolism 68, e240379, (2025)","journal-title":"Archives Endocrinol. Metabolism"},{"key":"4563_CR69","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S2213-8587(18)30113-X","volume":"6","author":"M Schlumberger","year":"2018","unstructured":"M. Schlumberger, S. Leboulleux, B. Catargi, D. Deandreis, S. Zerdoud et al., Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. Lancet Diabetes Endocrinol. 6, 618\u2013626 (2018)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4563_CR70","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","volume":"366","author":"U Mallick","year":"2012","unstructured":"U. Mallick, C. Harmer, B. Yap, J. Wadsley, S. Clarke et al., Ablation with Low-Dose radioiodine and Thyrotropin Alfa in thyroid cancer. N. Engl. J. Med. 366, 1674\u20131685 (2012)","journal-title":"N. Engl. J. Med."},{"key":"4563_CR71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S2213-8587(18)30306-1","volume":"7","author":"HM Dehbi","year":"2019","unstructured":"H.M. Dehbi, U. Mallick, J. Wadsley, K. Newbold, C. Harmer et al., Recurrence after low-dose radioiodine ablation and Recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. Lancet Diabetes Endocrinol. 7, 44\u201351 (2019)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4563_CR72","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S2213-8587(18)30113-X","volume":"6","author":"M. Schlumberger","year":"2018","unstructured":"M. Schlumberger, S. Leboulleux, B. Catargi, D. Deandreis, S. Zerdoud et al., Outcome after ablation in patients with low-risk thyroid cancer (ESTIM ABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. Lancet Diabetes Endocrinol. 6, 618\u2013626 (2018)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4563_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0140-6736(25)00629-4","volume":"406","author":"U Mallick","year":"2025","unstructured":"U. Mallick, K. Newbold, M. Beasley, K. Garcez, J. Wadsley et al., Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial. Lancet. 406, 52\u201362 (2025)","journal-title":"Lancet"},{"key":"4563_CR74","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa2111953","volume":"386","author":"S Leboulleux","year":"2022","unstructured":"S. Leboulleux, C. Bournaud, C.N. Chougnet, S. Zerdoud, A.A. Ghuzlan et al., Thyroidectomy without radioiodine in patients with Low-Risk thyroid cancer. N. Engl. J. Med. 386, 923\u2013932 (2022)","journal-title":"N. Engl. J. Med."},{"key":"4563_CR75","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12020-023-03336-4","volume":"80","author":"F Basolo","year":"2023","unstructured":"F. Basolo, E. Macerola, A.M. Poma, L. Torregrossa, The 5(th) edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma. Endocrine. 80, 470\u2013476 (2023)","journal-title":"Endocrine"},{"key":"4563_CR76","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3803\/EnM.2024.401","volume":"39","author":"M Kim","year":"2024","unstructured":"M. Kim, Levothyroxine dosing for thyroid-Stimulating hormone suppression in patients with differentiated thyroid cancer after total thyroidectomy. Endocrinol. Metab. 39, 576\u2013578 (2024)","journal-title":"Endocrinol. Metab."},{"key":"4563_CR77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"B Biondi","year":"2008","unstructured":"B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76\u2013131 (2008)","journal-title":"Endocr. Rev."},{"key":"4563_CR78","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/thy.2021.0666","volume":"32","author":"R Chou","year":"2022","unstructured":"R. Chou, T. Dana, G.A. Brent, W. Goldner, M. Haymart et al., Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: A systematic review. Thyroid. 32, 613\u2013639 (2022)","journal-title":"Thyroid"},{"key":"4563_CR79","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/thy.2010.0145","volume":"21","author":"PW Rosario","year":"2011","unstructured":"P.W. Rosario, A.C. Xavier, M.R. Calsolari, Value of postoperative thyroglobulin and ultrasonography for the indication of ablation and \u00b9\u00b3\u00b9I activity in patients with thyroid cancer and low risk of recurrence. Thyroid. 21, 49\u201353 (2011)","journal-title":"Thyroid"},{"key":"4563_CR80","doi-asserted-by":"publisher","first-page":"106563","DOI":"10.1016\/j.oraloncology.2023.106563","volume":"146","author":"H Hei","year":"2023","unstructured":"H. Hei, Z. Luo, C. Zheng, W. Gong, B. Zhou et al., Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer. Oral Oncol. 146, 106563 (2023)","journal-title":"Oral Oncol."},{"key":"4563_CR81","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1200\/JCO.2015.61.6722","volume":"33","author":"I Borget","year":"2015","unstructured":"I. Borget, J. Bonastre, B. Catargi, D. D\u00e9andr\u00e9is, S. Zerdoud et al., Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer: results from the randomized phase III ESTIMABL trial. J. Clin. Oncol. 33, 2885\u20132892 (2015)","journal-title":"J. Clin. Oncol."},{"key":"4563_CR82","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jss.2022.01.019","volume":"275","author":"CM Paluskievicz","year":"2022","unstructured":"C.M. Paluskievicz, D.R. Chang, K.W. Blackburn, D.J. Turner, K.M. Munir et al., Low-risk papillary thyroid cancer: treatment de-escalation and cost implications. J. Surg. Res. 275, 273\u2013280 (2022)","journal-title":"J. Surg. Res."},{"key":"4563_CR83","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.surg.2021.05.057","volume":"171","author":"MR Youssef","year":"2022","unstructured":"M.R. Youssef, A.S. Attia, M. Omar, M. Aboueisha, M.N. Freeman et al., Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance. Surgery. 171, 190\u2013196 (2022)","journal-title":"Surgery"},{"issue":"34","key":"4563_CR84","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3346\/jkms.2023.38.e264","volume":"38","author":"H.-S. Baek","year":"2023","unstructured":"H.-S. Baek, J. Ha, K. Kim, J. Bae, J.S. Kim et al., Cost-effectiveness of active surveillance compared to early surgery of small papillary thyroid cancer: a retrospective study on a Korean population. J. Korean Med. Sci. 38(34), e264 (2023)","journal-title":"J. Korean Med. Sci."},{"key":"4563_CR85","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.2147\/CMAR.S317627","volume":"13","author":"HS Baek","year":"2021","unstructured":"H.S. Baek, C.H. Jeong, J. Ha, J.S. Bae, J.S. Kim et al., Cost-Effectiveness analysis of active surveillance compared to early surgery in small papillary thyroid cancer: A systemic review. Cancer Manag Res. 13, 6721\u20136730 (2021)","journal-title":"Cancer Manag Res."},{"key":"4563_CR86","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12020-024-03864-7","volume":"85","author":"E Papini","year":"2024","unstructured":"E. Papini, R. Guglielmi, R. Novizio, A. Pontecorvi, C. Durante, Management of low-risk papillary thyroid cancer. Minimally-invasive treatments dictate a further paradigm shift? Endocrine. 85, 584\u2013592 (2024)","journal-title":"Endocrine"},{"key":"4563_CR87","doi-asserted-by":"publisher","first-page":"e25536","DOI":"10.1016\/j.heliyon.2024.e25536","volume":"10","author":"B Li","year":"2024","unstructured":"B. Li, Y. Qian, Y. Huang, Z. Li, Efficacy and safety of thermal ablation modalities for the treatment of papillary thyroid microcarcinoma: systematic review and network meta-analysis. Heliyon. 10, e25536 (2024)","journal-title":"Heliyon"},{"key":"4563_CR88","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1089\/thy.2022.0325","volume":"32","author":"RM Tuttle","year":"2022","unstructured":"R.M. Tuttle, J. Fagin, G. Minkowitz, R. Wong, B. Roman et al., Active surveillance of papillary thyroid cancer: frequency and time course of the six most common tumor volume kinetic patterns. Thyroid. 32, 1337\u20131345 (2022)","journal-title":"Thyroid"},{"key":"4563_CR89","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1210\/clinem\/dgz113","volume":"105","author":"E Molinaro","year":"2020","unstructured":"E. Molinaro, M.C. Campopiano, L. Pieruzzi, A. Matrone, L. Agate et al., Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian center. J. Clin. Endocrinol. Metab. 105, e172\u2013180 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4563_CR90","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ejso.2017.06.004","volume":"44","author":"JR Cracchiolo","year":"2018","unstructured":"J.R. Cracchiolo, R.J. Wong, Management of the lateral neck in well differentiated thyroid cancer. Eur. J. Surg. Oncol. 44, 332\u2013337 (2018)","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04563-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04563-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04563-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T22:03:04Z","timestamp":1771279384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04563-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4563"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04563-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No potential conflict of interest was reported by the author(s).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"conflict of interests"}}],"article-number":"85"}}